BIOMAT Database Logo BIOMAT Database Logo

[Clinical experiences with benzydamine hydrochloride (Riripen) in otolaryngology]. 1968

H Igarashi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010038 Otorhinolaryngologic Diseases Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases. Otolaryngologic Diseases,ENT Diseases,Otolaryngological Diseases,Otorhinolaryngologic Disease,Otorhinolaryngological Disease,Disease, ENT,Disease, Otolaryngologic,Disease, Otolaryngological,Disease, Otorhinolaryngologic,Disease, Otorhinolaryngological,Diseases, ENT,Diseases, Otolaryngologic,Diseases, Otolaryngological,Diseases, Otorhinolaryngologic,Diseases, Otorhinolaryngological,ENT Disease,Otolaryngologic Disease,Otolaryngological Disease,Otorhinolaryngological Diseases
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

H Igarashi
[Clinical experience with Riripen tablet (benzydamine hydrochloride) in otorhinolaryngology].
March 1968, Jibi inkoka Otolaryngology,
H Igarashi
[Clinical experience with benzydamine hydrochloride (Riripen) in inflammatory diseases of the pharynx and the larynx].
March 1968, Jibi inkoka Otolaryngology,
H Igarashi
A clinical evaluation of benzydamine hydrochloride.
April 1978, Australian dental journal,
H Igarashi
[Experiences with a new preparation, Tantum biotic. (Benzydamine hydrochloride + tetracycline) in a surgical clinic].
December 1970, Zeitschrift fur Allgemeinmedizin,
H Igarashi
Metabolism of benzydamine hydrochloride.
July 1971, Chemical & pharmaceutical bulletin,
H Igarashi
[Clinical experiences with the association of benzydamine and tetracycline].
February 1968, Minerva medica,
H Igarashi
Recreational abuse with benzydamine hydrochloride (tantum rosa).
January 2007, Clinical toxicology (Philadelphia, Pa.),
H Igarashi
[Clinical studies on the effect of benzydamine hydrochloride in episiotomies].
May 1969, Die Medizinische Welt,
H Igarashi
CLINICAL EXPERIENCES WITH MEPIVACAINE HYDROCHLORIDE.
January 1964, Anesthesia and analgesia,
H Igarashi
Contact dermatitis from benzydamine hydrochloride.
August 1986, Contact dermatitis,
Copied contents to your clipboard!